Multimodal Hyperspectroscopy : The Use of Digital Technology in Cervical Cancer Screening – Orv Hetil,  Krasznai ZT, et al, 16 May 2021

The Performance of Multimodal Hyperspectral Spectroscopy in the Detection of Precancerous Cervical Lesions – European journal of Gynaecological Oncology Demir, Ömer et al. 15 April 2020

LuViva as a Screening Tool in Cervical Neoplasia: Analysis on 58 Women in Costa Rica– Crónicas Científicas,  Salazar-Mora, R; et al, 3 July 2019

The Performance of Multimodal Hyperspectral Spectroscopy in the Detection of Precancerous Cervical Lesions – Journal of Physics, Trahmono et al 2017

Multimodal Hyperspectroscopy as a Triage Test for Cervical Neoplasia: Pivotal Clinical Trial Results– Gynecologic Oncology, Leo Twiggs, MD, et al,  1 July 2013  – LuViva® Advanced Cervical Scan

Is Colposcopy and/or Biopsy Always Necessary?– Hospital Healthcare Europe 2013 – LuViva® Advanced Cervical Scan

Comparison of Human Papilloma Virus Testing and Spectroscopy Combined With Cervical Cytology for the Detection of High-grade Cervical Neoplasia – Journal of Lower Genital Tract Disease, April 2007 – LuViva® Advanced Cervical Scan

Spectroscopic Imaging as a Triage Test for Cervical Disease: A Prospective Multicenter Clinical Trial – Journal of Lower Genital Tract Disease, January 2006 – LuViva® Advanced Cervical Scan

Women’s Responses to Cervical Interrogation by Fluorescent and Reflective Spectroscopy– Journal of Lower Genital Tract Disease, April 2003 – LuViva® Advanced Cervical Scan

Multimodal Hyperspectral Imaging for the Noninvasive Diagnosis of Cervical Neoplasia – Journal of Lower Genital Tract Disease, October 2001 – LuViva® Advanced Cervical Scan

XXIX FIGO World Congress 2015 Abnormal Spectroscopy Scans May Presage Persistent or Progressive Cervical Dysplasia – Leo B. Twiggs, M.D. – LuViva® Advanced Cervical Scan

Turkish Society of Gynecology Oncology Congress (TSGO) 2014 –Biophotonic Detection of Cervical Dysplasia: The Transition from Clinical Trials to Real World Use– Leo B. Twiggs, M.D. – LuViva® Advanced Cervical Scan

European Congress of Obstetrics and Gynaecology (EBCOG) 2010 –  Multimodal Spectroscopy as a Triage Test for Women at Risk for cervical neoplasia: Results of a 1,607 subject pivotal trial–  Nahida Chakhtoura, M.D. – LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 –Multimodal Spectroscopy as a Triage Test for Women at Risk for cervical neoplasia: Results of a 1,607 subject pivotal trial –– Leo B. Twiggs, M.D. – LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal Spectroscopy as a Triage Test for Women at Risk for cervical neoplasia: Results of follow up data – Nahida Chakhtoura, M.D. – LuViva® Advanced Cervical Scan

INCOLO 2007 –Quantitative Optical Spectroscopy of the Uterine Cervix: A cost effective way to detect and manage cervical disease – Nahida Chakhtoura, M.D. – LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2006 –Comparison of HPV Testing and spectroscopy combined with cytology for the detection of high-grade cervical Neoplasia – Claudia Werner, M.D. – LuViva® Advanced Cervical Scan

European Research Organisation on Genital Infection and Neoplasia (EUROGIN) 2003Multimodal spectroscopic imaging of the cervix for triaging patients to colposcopy – Leo B. Twiggs, M.D. – LuViva® Advanced Cervical Scan

Society of Gynecology and Obstetrics of Nigeria 2014 – Results of LuViva Test with Comparisons to Other Tests – Cytology, HPV, VIA and Histopathology – Principal Investigator for cervical cancer in Nigeria: Professor Isaac Adewole, Co-Principal Investigator: Dr. O. Awolude

Society of Gynecology and Obstetrics of Nigeria 2014 – Cervical Screening with LuViva Machice for Early Detection of Cervical Dysplasia: Experience from Ekiti State, Nigeria – Professor Olusola B. et al

International Federation of Cervical Pathology and Colposcopy (IFCPC) 2014 – LuViva Cervical Scan as a triage test to reduce unnecessary colposcopy and biopsyLuViva Cervical Scan as a triage test to reduce unnecessary colposcopy and biopsy – James Bentley, MBChB FRCSC– LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2012 – Preliminary Assessment of cervical spectroscopy for primary screening of moderate and high grade cervical dysplasiaPreliminary Assessment of cervical spectroscopy for primary screening of moderate and high grade cervical dysplasia – Lisa C. Flowers, M.D. – LuViva® Advanced Cervical Scan

American Congress of Obstetricians and Gynecologists (ACOG) 2012 – Optimal Combination of cervical spectroscopy with cytology and HPV: Implications for Clinic efficiencyOptimal Combination of cervical spectroscopy with cytology and HPV: Implications for Clinic efficiency – Marc L. Winter, M.D. – LuViva® Advanced Cervical Scan

International Society for Optics and Photonics, Photonics West 2011 – Identifying Constituent Spectra Sources in Multispectral Images to Quantify and Locate Cervical NeoplasiaIdentifying Constituent Spectra Sources in Multispectral Images to Quantify and Locate Cervical Neoplasia – LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal spectroscopy as a triage test for women at risk for cervical neoplasia: experience with a low cost commercial prototypeMultimodal spectroscopy as a triage test for women at risk for cervical neoplasia: experience with a low cost commercial prototype – Marc L. Winter, M.D. – LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal spectroscopy as a triage test for women at risk for cervical neoplasia: Histopathology review procedures and resultsMultimodal spectroscopy as a triage test for women at risk for cervical neoplasia: Histopathology review procedures and results – Ed J. Wilkinson, M.D. – LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal spectroscopy as a triage test for women at risk for cervical neoplasia: Results for Adolescent PatientsMultimodal spectroscopy as a triage test for women at risk for cervical neoplasia: Results for Adolescent Patients – Lisa C. Flowers, M.D. – LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2008 – Quantitative Optical spectroscopy offers a cost effective method for diagnosing cervical cancerQuantitative Optical spectroscopy offers a cost effective method for diagnosing cervical cancer

American Society for Colposcopy and Cervical Pathology (ASCCP) 2006 – Spectroscopic Imaging as a triage test for cervical disease: A prospective multicenter clinical trialSpectroscopic Imaging as a triage test for cervical disease: A prospective multicenter clinical trial – Timothy DeSantis, M.D. – LuViva® Advanced Cervical Scan